|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 482.13 USD | +3.17% |
|
-14.18% | -19.75% |
| 07-30 | Madrigal Pharmaceuticals Q2 Loss Widens, Revenue Increases | MT |
| 07-30 | Madrigal Pharmaceuticals, Inc., Q2 2026 Earnings Call, Jul 30, 2026 |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +3.17% | -14.18% | -11.51% | -9.03% | -19.75% | +54.65% | +135.46% | +431.53% | +6,547.51% | 10.8B | |
| +2.35% | +2.74% | +5.88% | +17.23% | +41.69% | +38.10% | +74.02% | -15.95% | - | 56.54B | |
| -2.20% | -6.51% | -11.12% | +7.89% | +3.01% | +25.66% | +62.29% | +183.45% | +5,691.37% | 53.6B | |
| +2.14% | +1.40% | -7.14% | -7.14% | -4.85% | -15.61% | -13.72% | -73.38% | - | 22.91B | |
| +0.31% | -7.78% | -11.65% | -26.01% | -43.35% | -9.28% | +352.92% | +308.62% | +766.43% | 21.37B | |
| +0.15% | +0.36% | +3.30% | +12.27% | +23.41% | +24.28% | -14.44% | -69.26% | - | 20.27B | |
| -0.66% | -2.28% | -0.21% | +9.19% | -8.02% | +31.86% | -29.13% | -35.75% | +55.12% | 17.56B | |
| -1.45% | -7.15% | -4.45% | +3.43% | +21.57% | +17.96% | +554.50% | - | - | 14.75B | |
| +3.41% | -6.61% | -15.71% | +77.89% | +150.18% | +162.81% | +287.77% | +1,256.40% | +603.43% | 13.53B | |
| +1.06% | -4.23% | -5.05% | +21.41% | +20.99% | +42.32% | +160.72% | +207.78% | +479.56% | 13.33B | |
| -0.04% | -1.11% | +0.79% | +13.15% | +27.50% | +431.39% | +156.75% | +24.47% | +1,374.74% | 11.92B | |
| -2.24% | -6.85% | -10.30% | -28.13% | -18.72% | -39.61% | +141.71% | +80.10% | - | 11.04B | |
| -0.64% | -4.47% | -10.82% | +21.75% | +21.39% | +110.22% | +148.17% | +168.09% | +559.79% | 10.47B | |
| +0.88% | -4.69% | -15.56% | -19.21% | -25.56% | -51.90% | +567.69% | +68.00% | +86.05% | 10.39B | |
| +0.02% | -.--% | +0.19% | +25.16% | +23.23% | +59.41% | +166.07% | +465.77% | - | 9.83B | |
| +0.27% | -0.25% | +97.77% | +114.04% | +79.42% | +200.00% | +335.68% | +376.71% | - | 8.81B | |
| -2.69% | -3.72% | +13.51% | +41.65% | +200.15% | +504.74% | +612.15% | -36.05% | -14.12% | 8.65B | |
| +0.74% | -.--% | -.--% | -.--% | -.--% | -.--% | +70.76% | +79.55% | - | 8.19B | |
| -3.91% | -8.29% | -10.54% | -19.97% | +9.10% | +32.80% | +88.14% | -21.17% | - | 8.08B | |
| +0.30% | -1.06% | -7.38% | -5.01% | +17.21% | +63.78% | +7.62% | +140.57% | - | 7.81B | |
| Average | -1.44% | -3.54% | -0.00% | +12.53% | +25.93% | +84.18% | +193.26% | +186.29% | +1,614.99% | 16.99B | |
| Weighted average by Cap. | -0.79% | -3.15% | -1.84% | +10.79% | +21.12% | +60.15% | +152.24% | +150.88% | +2,509.46% |
- Stock Market
- Stocks
- MDGL Stock
- Sector Madrigal Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
